The synergistic effects of saxagliptin and metformin on CD34+ endothelial progenitor cells in early type 2 diabetes patients: a randomized clinical trial

AIMS: Type 2 diabetes is associated with endothelial dysfunction leading to cardiovascular disease. CD34+ endothelial Progenitor Cells (EPCs) are responsible for endothelial repair and neo-angiogenesis and can be used as a cardiovascular disease risk biomarker. This study investigated whether the ad...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cardiovasc Diabetol
Päätekijät: Dore, Fiona J., Domingues, Cleyton C., Ahmadi, Neeki, Kundu, Nabanita, Kropotova, Yana, Houston, Sara, Rouphael, Carol, Mammadova, Aytan, Witkin, Linda, Khiyami, Anamil, Amdur, Richard L., Sen, Sabyasachi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2018
Aiheet:
Original Investigation
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5934787/
https://ncbi.nlm.nih.gov/pubmed/29724198
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-018-0709-9
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia